HOME | CONTACT US | LOGIN | REGISTER
 
INVESTOR RELATIONS
Investor Home
Stock Quote/Chart
Stock Price Lookup
Calculator
Events & Presentations
Annual Meeting
News Releases
SEC Filings
Information Request
Email Alerts
 
  Investor Tool Kit
  PDF Corporate Fact Sheet
  PDF Investor Presentation
  HTML file Annual Report & Proxy
 
 
NASDAQ: GNBT 0.41 + 0.01
2 Sep 2010 1:05 PM ET
 
Print Print   Email Email page
 
 
Press Releases
 
Generex Oncology Announces Consultancy of Dr. George E. Peoples, MD
  2 Sep 2010
   
Generex Biotechnology Initiates Social Media Campaign for Its Corporate and e-Commerce Websites
  1 Sep 2010
   
Generex Informs Stockholders of Minimum Exchange Ratio for Reverse Stock Split Proposal to be Considered at the Special Meeting of Stockholders on September 17, 2010
  27 Aug 2010
   
Generex Oncology Names Dr. Craig Eagle to Its Scientific Advisory Board to Assist With Its Proprietary Cancer Vaccines Program
  5 Aug 2010
   
Generex Biotechnology Creates Scientific Advisory Board to Further the Progression of Its Drug Development Programs
  2 Aug 2010
   
Generex Announces AGM Results
  30 Jul 2010
   
Generex Provides Positive Update On Generex Oral-Lyn(TM) Pivotal Phase III Trial
  28 Jul 2010
   
Generex's Glucose RapidSpray(TM) Now Available at Boots UK Retail Chain Stores
  15 Jul 2010
   
Generex Announces Receipt of Favorable NASDAQ Listing Determination
  15 Jul 2010
   
Generex Oncology Granted United States Patent for AE37 Peptide Vaccine
  13 Jul 2010
   
Generex Biotechnology Participates in Gateway to China Business Round Table Conference
  7 Jul 2010
   
Generex Biotechnology to Participate in World's Largest and Most Prestigious Diabetes Meeting
  22 Jun 2010
   
Generex Oncology Announces Presentations at the American Society of Clinical Oncology Annual Meeting and the 7th World Vaccine Conference
  9 Jun 2010
   
Generex Biotechnology Reports Preliminary Outcomes and Trends From Ongoing Phase III Clinical Trial of Generex Oral-lyn(TM)
  7 Jun 2010
   
Generex Awarded Two New Patents for Its Proprietary Buccal Drug Delivery System
  1 Jun 2010
   
Generex Biotechnology to Participate in American Society of Clinical Oncology Annual Meeting in Chicago
  26 May 2010
   
Generex Biotechnology Announces Publication of Novel Immunotherapeutic Cancer Vaccine Results in Patients With Prostate Cancer
  18 May 2010
   
Generex Biotechnology Hosts Satellite Symposium at CODHy 2010
  13 May 2010
   
Generex Biotechnology Achieves Enrollment of Over 400 Subjects in Phase III Generex Oral-lyn(TM) Study
  10 May 2010
   
Generex Receives NASDAQ Non-Compliance Notice
  7 May 2010
   
Generex Receives New US Patent for Its Proprietary Buccal Drug Delivery Platform Technologies
  29 Apr 2010
   
Generex Announces Updated Phase I Results From Novel Immunotherapeutic Vaccine Presented at the European Association of Urology Congress
  27 Apr 2010
   
Generex Establishes Action Plan for Reimbursement Coverage for Generex Oral-lyn(TM)
  19 Apr 2010
   
Generex Announces New Treatment IND Site for the USFDA Expanded Access Treatment IND Program for Generex Oral-lyn(tm) in the United States
  13 Apr 2010
   
Generex Receives Funding Commitment
  8 Apr 2010
   
Generex Launches $250,000,000 Lawsuit Against TheStreet.com and Feuerstein
  6 Apr 2010
   
Generex Announces Expansion Plan for the U.S. FDA Expanded Access Treatment IND Program for Generex Oral-lyn(TM) in the United States
  29 Mar 2010
   
Generex Biotechnology Demands Retraction of False and Misleading Article
  23 Mar 2010
   
Generex Oral-lyn(TM) Presentation at CODHy Congress
  16 Mar 2010
   
Generex Receives Positive Responses From Independent Physicians and Nurse Practitioners in Recent Focus Groups Conducted in the United States for Generex Oral-lyn(TM)
  11 Mar 2010
   
Generex Establishes Key Strategic Relationships for the Development of a Distribution Network for Generex Oral-lyn(R) Under the FDA's Expanded Access Treatment IND Program
  4 Mar 2010
   
Generex Subsidiary Antigen Express Receives Patent in China for Its Ii-Key Peptide Vaccine Technology
  2 Mar 2010
   
Generex Announces Participation in 2010 Arab Health Congress
  25 Jan 2010
   
Generex Biotechnology Highlights OTC Product Line at The Vitamin, Diet & Sports Nutrition Efficient Program Planning Session
  20 Jan 2010
   
Generex Makes Podium Presentation of Vaccine Technology Platform With Cancer & Influenza Updates at PepTalk 2010
  19 Jan 2010
   
Generex Biotechnology Corporation: Introducing Revolutionary Cancer Immunotherapy While Redefining the Treatment for T1D, T2D
  14 Jan 2010
   
Generex Biotechnology Corporation to Present at the OneMedForum 2010 Conference
  13 Jan 2010
   
Generex Receives Over $800,000 in Initial Purchase Orders for Crave-NX(TM) 7-Day Diet Aid Spray
  13 Jan 2010
   
Major U.S. Pharmacy Chain to Market Generex's Crave-NX(TM) 7-Day Diet Aid Spray Throughout Its Nationwide Network of Over 7,000 Stores
  11 Jan 2010
   
Generex: a Year in Review; Setting the Stage for a Year of Progress (Part Three)
  8 Jan 2010
   
Showing 1-40 of 381 Page: 1 2 3 ... 10  Next 40
 
 
Privacy Policy